RNA vs SWK · rev $22.6M vs P/E 34, rev $7.81B
Atrium Therapeutics, Inc. Common Stock (RNA) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
RNA currently screens at market cap $217.5M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the RNA and SWK stock pages for the full models.
Not investment advice.